Castle Biosciences, Inc.
USD23.59
-0.73 (-3.00%)
CEO
Derek J. Maetzold
IPO Date
2019-07-25
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NASDAQ
Country
US
Open
$24.42
Prev. Close
$24.32
Day Low
$23.50
Day High
$24.42
52W Low
$14.59
52W High
$44.28
Market Cap
$0.72B
Volume
0.04M
| 40.6 |
| 31 Dec 2023 | FY | 79.5% | -26.1% | -14.7% | -12.7% | 0.04 | 6.20 | -10.1 |
| 31 Dec 2022 | FY | 76.6% | -49.0% | -16.8% | -15.0% | 0.03 | 8.09 | -9.1 |
| 31 Dec 2021 | FY | 83.2% | -33.3% | -7.6% | -6.8% | 0.02 | 14.21 | -34.4 |
| 31 Dec 2020 | FY | 84.5% | -16.4% | -2.5% | -2.3% | 0.00 | 20.58 | -123.6 |
| 31 Dec 2019 | FY | 85.9% | 10.2% | 6.2% | 4.4% | 0.30 | 7.63 | 55.9 |
| 31 Dec 2018 | FY | 76.8% | -27.9% | 63.2% | -28.4% | -2.43 | 2.69 | -35.8 |
| 31 Dec 2017 | FY | 64.2% | -89.9% | 86.7% | -126.0% | -1.30 | 1.28 | -16.9 |
| -122.3 |
| 30 Sept 2025 | Q3 | 77.5% | -0.6% | -0.1% | -0.1% | 0.08 | 6.47 | -284.6 |
| 30 Jun 2025 | Q2 | 79.5% | 5.2% | 1.0% | 0.8% | 0.08 | 6.85 | 32.6 |
| 31 Mar 2025 | Q1 | 81.4% | -29.4% | -5.9% | -5.2% | 0.06 | 9.37 | -5.5 |
| 31 Dec 2024 | Q4 | 81.3% | 11.1% | 2.1% | 1.8% | 0.06 | 7.29 | 19.5 |
| 30 Sept 2024 | Q3 | 81.8% | 2.6% | 0.5% | 0.4% | 0.06 | 7.78 | 87.5 |
| 30 Jun 2024 | Q2 | 83.3% | 10.3% | 2.1% | 1.8% | 0.06 | 8.12 | 16.4 |
| 31 Mar 2024 | Q1 | 81.0% | -3.5% | -0.6% | -0.6% | 0.06 | 9.25 | -60.3 |
| 31 Dec 2023 | Q4 | 81.2% | -3.9% | -0.7% | -0.6% | 0.04 | 6.20 | -56.8 |